Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing: Are there any differences using insulin lispro compared to regular insulin?

Kevin C J Yuen, Rakesh Amin, Marie B. Cook, Sharon A. Rhoads, David M. Cook

Research output: Contribution to journalArticle

Abstract

Background/Aim: The insulin tolerance test (ITT) remains the gold standard for evaluating the pituitary function, but has potential risks when hypoglycaemia is induced. There are scarce data using short-acting insulin analogs for ITTs. This pilot study compares the effects of insulin lispro (LPI) with regular insulin (RGI) during an ITT. Methods: Patients with suspected hypopituitarism (n = 103) randomly received either LPI (n = 51) or RGI (n = 52). Results: All patients reported signs and symptoms when hypoglycaemia was induced. In the LPI group, hypoglycaemia occurred sooner (23.6 ± 1.6 vs. 28.3 ± 1.4 min, p <0.05), and duration of hypoglycaemia (25.0 ± 1.7 vs. 31.9 ± 1.9 min, p <0.05) and time for blood glucose levels to return to a 'safe' level (>3.3 mmol/l; 56.5 ± 2.3 vs. 76.0 ± 2.1 min, p <0.001) were shorter as compared with the RGI group. No differences in peak growth hormone and cortisol levels were observed between the two groups. Conclusions: Our data suggest that despite inducing similar symptomatology, LPI exerted a quicker onset and a shorter duration of hypoglycaemia as compared with RGI. Thus, using LPI might reduce the potential risks associated with an ITT by shortening the hypoglycaemic phase of the test.

Original languageEnglish (US)
Pages (from-to)233-239
Number of pages7
JournalHormone Research
Volume69
Issue number4
DOIs
StatePublished - 2008

Fingerprint

Insulin Lispro
Hypoglycemia
Insulin
Short-Acting Insulin
Hypopituitarism
Hypoglycemic Agents
Growth Hormone
Signs and Symptoms
Hydrocortisone

Keywords

  • Hypoglycaemia
  • Insulin lispro
  • Insulin tolerance test
  • Regular insulin

ASJC Scopus subject areas

  • Endocrinology

Cite this

Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing : Are there any differences using insulin lispro compared to regular insulin? / Yuen, Kevin C J; Amin, Rakesh; Cook, Marie B.; Rhoads, Sharon A.; Cook, David M.

In: Hormone Research, Vol. 69, No. 4, 2008, p. 233-239.

Research output: Contribution to journalArticle

Yuen, Kevin C J ; Amin, Rakesh ; Cook, Marie B. ; Rhoads, Sharon A. ; Cook, David M. / Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing : Are there any differences using insulin lispro compared to regular insulin?. In: Hormone Research. 2008 ; Vol. 69, No. 4. pp. 233-239.
@article{55afc6d254dd4ea0bbd409d3ab5b4f28,
title = "Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing: Are there any differences using insulin lispro compared to regular insulin?",
abstract = "Background/Aim: The insulin tolerance test (ITT) remains the gold standard for evaluating the pituitary function, but has potential risks when hypoglycaemia is induced. There are scarce data using short-acting insulin analogs for ITTs. This pilot study compares the effects of insulin lispro (LPI) with regular insulin (RGI) during an ITT. Methods: Patients with suspected hypopituitarism (n = 103) randomly received either LPI (n = 51) or RGI (n = 52). Results: All patients reported signs and symptoms when hypoglycaemia was induced. In the LPI group, hypoglycaemia occurred sooner (23.6 ± 1.6 vs. 28.3 ± 1.4 min, p <0.05), and duration of hypoglycaemia (25.0 ± 1.7 vs. 31.9 ± 1.9 min, p <0.05) and time for blood glucose levels to return to a 'safe' level (>3.3 mmol/l; 56.5 ± 2.3 vs. 76.0 ± 2.1 min, p <0.001) were shorter as compared with the RGI group. No differences in peak growth hormone and cortisol levels were observed between the two groups. Conclusions: Our data suggest that despite inducing similar symptomatology, LPI exerted a quicker onset and a shorter duration of hypoglycaemia as compared with RGI. Thus, using LPI might reduce the potential risks associated with an ITT by shortening the hypoglycaemic phase of the test.",
keywords = "Hypoglycaemia, Insulin lispro, Insulin tolerance test, Regular insulin",
author = "Yuen, {Kevin C J} and Rakesh Amin and Cook, {Marie B.} and Rhoads, {Sharon A.} and Cook, {David M.}",
year = "2008",
doi = "10.1159/000113024",
language = "English (US)",
volume = "69",
pages = "233--239",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing

T2 - Are there any differences using insulin lispro compared to regular insulin?

AU - Yuen, Kevin C J

AU - Amin, Rakesh

AU - Cook, Marie B.

AU - Rhoads, Sharon A.

AU - Cook, David M.

PY - 2008

Y1 - 2008

N2 - Background/Aim: The insulin tolerance test (ITT) remains the gold standard for evaluating the pituitary function, but has potential risks when hypoglycaemia is induced. There are scarce data using short-acting insulin analogs for ITTs. This pilot study compares the effects of insulin lispro (LPI) with regular insulin (RGI) during an ITT. Methods: Patients with suspected hypopituitarism (n = 103) randomly received either LPI (n = 51) or RGI (n = 52). Results: All patients reported signs and symptoms when hypoglycaemia was induced. In the LPI group, hypoglycaemia occurred sooner (23.6 ± 1.6 vs. 28.3 ± 1.4 min, p <0.05), and duration of hypoglycaemia (25.0 ± 1.7 vs. 31.9 ± 1.9 min, p <0.05) and time for blood glucose levels to return to a 'safe' level (>3.3 mmol/l; 56.5 ± 2.3 vs. 76.0 ± 2.1 min, p <0.001) were shorter as compared with the RGI group. No differences in peak growth hormone and cortisol levels were observed between the two groups. Conclusions: Our data suggest that despite inducing similar symptomatology, LPI exerted a quicker onset and a shorter duration of hypoglycaemia as compared with RGI. Thus, using LPI might reduce the potential risks associated with an ITT by shortening the hypoglycaemic phase of the test.

AB - Background/Aim: The insulin tolerance test (ITT) remains the gold standard for evaluating the pituitary function, but has potential risks when hypoglycaemia is induced. There are scarce data using short-acting insulin analogs for ITTs. This pilot study compares the effects of insulin lispro (LPI) with regular insulin (RGI) during an ITT. Methods: Patients with suspected hypopituitarism (n = 103) randomly received either LPI (n = 51) or RGI (n = 52). Results: All patients reported signs and symptoms when hypoglycaemia was induced. In the LPI group, hypoglycaemia occurred sooner (23.6 ± 1.6 vs. 28.3 ± 1.4 min, p <0.05), and duration of hypoglycaemia (25.0 ± 1.7 vs. 31.9 ± 1.9 min, p <0.05) and time for blood glucose levels to return to a 'safe' level (>3.3 mmol/l; 56.5 ± 2.3 vs. 76.0 ± 2.1 min, p <0.001) were shorter as compared with the RGI group. No differences in peak growth hormone and cortisol levels were observed between the two groups. Conclusions: Our data suggest that despite inducing similar symptomatology, LPI exerted a quicker onset and a shorter duration of hypoglycaemia as compared with RGI. Thus, using LPI might reduce the potential risks associated with an ITT by shortening the hypoglycaemic phase of the test.

KW - Hypoglycaemia

KW - Insulin lispro

KW - Insulin tolerance test

KW - Regular insulin

UR - http://www.scopus.com/inward/record.url?scp=42449118506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449118506&partnerID=8YFLogxK

U2 - 10.1159/000113024

DO - 10.1159/000113024

M3 - Article

C2 - 18204271

AN - SCOPUS:42449118506

VL - 69

SP - 233

EP - 239

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 4

ER -